Castle Biosciences Advances Barrett’s Risk Testing With TissueCypher
Friendswood, Texas, U.S., September 28, 2026 Castle Biosciences has announced new clinical evidence demonstrating how its TissueCypher® Barrett’s Esophagus...
AI diagnostics
Advertisement
bioAffinity Technologies Advances CyPath Lung for Cancer Surveillance
SAN ANTONIO, September 1, 2026 bioAffinity Technologies, Inc. is advancing the potential use of its noninvasive CyPath® Lung test...
bioAffinity Technologies Reports CyPath Lung Growth
SAN ANTONIO, Texas, August 7, 2026 bioAffinity Technologies reported second quarter 2026 financial results highlighted by continued commercial momentum...
Apertura and FAST Partner on Angelman Gene Therapy Innovation
Austin, Texas & New York, August 5, 2026 The Foundation for Angelman Syndrome Therapeutics (FAST) has announced a strategic...
AEYE Health Study Validates AI for Diabetic Eye Screening
New York, August 4, 2026 AEYE Health has announced the publication of a real-world clinical study in the British...
Advertisements
SOPHiA GENETICS Partners with AstraZeneca on CDx
Boston, Massachusetts & Rolle, Switzerland, August 4, 2026 SOPHiA GENETICS has entered into a global multi-year collaboration with AstraZeneca...
Lilly’s Olomorasib Earns FDA Breakthrough Therapy Designation
Indianapolis, August 3, 2026 Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted...
Fresenius Kabi Gains FDA Approval for Rituximab Biosimilar
Bad Homburg, Germany, August 3, 2026 Fresenius Kabi, an operating company of Fresenius, announced that the U.S. Food and...
Invenio Imaging Completes Enrollment in AI Lung Cancer Study
San Jose, California, August 3, 2026 Invenio Imaging announced the completion of patient enrollment in the ON-SITE pivotal study,...
bioAffinity Technologies Publishes Clinical Framework for CyPath Lung
SAN ANTONIO, July 27, 2026 bioAffinity Technologies, Inc. announced the publication of a comprehensive clinical review and white paper...
Advertisement
